正在加载视频...

视频加载失败

Today, we announce progress in our Fabry disease program, achieving important derisking milestones in our pathway to anticipated BLA submission. Learn more:

16,994 次观看 • 1 年前 •via X (Twitter)

6 条评论

Dan 的头像
Dan1 年前

Where’s the partnership that you’ve been referencing for the past 10 months?

GothamGirl 的头像
GothamGirl1 年前

@sandymacrae23 @johnmarkels @Franca_ole Sangamo moved the goal post AGAIN - in Feb 6th PR you noted potential BLA submission 2nd 1/2 2025, now you note Q1 2026. 3-6 month delay means more dilution for current shareholders without a partnership or sale of Fabry asset near-term.

Jasper 的头像
Jasper1 年前

Lol what an achievement So proud of you guys 😂😂

NextChapter 的头像
NextChapter1 年前

Nobody cares. You’re going to the out of business since the bonehead CEO doesn’t know anything other than diluting shareholders and giving out false dates

똠양꿈 的头像
똠양꿈1 年前

Dillutuion again??

Trade Hatch 的头像
Trade Hatch1 年前

How do you spell bankruptcy? SANDYMACRAE! How this clown has been allowed to destroy this company and eviscerate its shareholders and employees is beyond me. Hands down the worst CEO of any biotech I have ever followed!

相关视频